Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Seqwork
    Junior Member
    • Mar 2014
    • 4

    Low library yield

    Hello Everyone,
    I am new person to RNA Seq work.I made libraries from FFPE RNA as per protocol.RNA input was from 0.5-1ug for different samples.
    But i can hardly see any yield on bioanalyzer and nanodrop readings are also 10ng/ul or below.
    This is disappointing for me.I have been careful.I don't know where i lost my nucleic acid.One thing which i can remember about Ribosomal RNA removal beads step ,those beads were really difficult to dissolve.
    Any suggestions will be welcomed.
    Thanks
  • kwaraska
    Senior Member
    • Nov 2008
    • 131

    #2
    10ng/ul for an RNAseq library is not low-it is in fact quite good.

    What does your bioanalyzer trace show?

    Comment

    • Seqwork
      Junior Member
      • Mar 2014
      • 4

      #3
      I made libraries twice.Both time nanodrop reading were 10ng/ul or below.
      But i checked my libraries only first time on bioanalyzer, and i can see something at right size around 230-260 but very small peaks.
      I have not checked my libraries second time at bioanalyzer, as i thought again i will not see anything.
      someone suggested me that i should see at least 30ng/ul at nanodrop, but obviously bioanalyzer is more accurate.
      what can i do to improve my yield.As i m planning to start it again.
      Thank you for replying.

      Comment

      Latest Articles

      Collapse

      • mylaser
        Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by mylaser
        Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
        If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
        This guide explains everything you need to know about...
        Today, 01:13 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      13 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      10 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-07-2026, 11:05 AM
      0 responses
      19 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-02-2026, 11:08 AM
      0 responses
      31 views
      0 reactions
      Last Post SEQadmin2  
      Working...